tiprankstipranks
Advertisement

REVS ETF Price & Analysis

Compare

REVS ETF Chart & Stats

$32.00
--
Market closed
$32.00
--

ETF Overview

Columbia Research Enhanced Value ETF

The Columbia Research Enhanced Value ETF (REVS) is a distinctive investment vehicle tailored for those seeking exposure to large-cap stocks with a pronounced value orientation. As a member of the Size and Style category, this ETF strategically focuses on the Value niche, targeting companies that are undervalued by the market yet possess strong fundamentals. The core objective of REVS is to deliver enhanced returns by leveraging Columbia's robust research framework, identifying stocks that offer potential for significant capital appreciation. REVS is meticulously designed to capitalize on inefficiencies within the large-cap segment, offering investors a diversified portfolio of companies that are not only financially sound but also trading at attractive valuations. By concentrating on value stocks, the ETF aims to exploit opportunities where market pessimism may have overshadowed the intrinsic worth of these companies. This focus can provide a cushion against market volatility, offering a blend of stability and growth potential. Ideal for investors looking to balance their portfolios with large-cap equities while emphasizing a value strategy, the Columbia Research Enhanced Value ETF stands out as a compelling choice. Its research-driven approach ensures that each holding is selected based on rigorous analysis, providing confidence that the ETF is well-positioned to deliver on its value-centric promise. Whether for long-term growth or strategic diversification, REVS offers a nuanced pathway to capitalize on the enduring appeal of value investing within the large-cap arena.

Columbia Research Enhanced Value ETF (REVS) Fund Flow Chart

Columbia Research Enhanced Value ETF (REVS) 1 year Net Flows: $200M

REVS ETF News

REVS ETF FAQ

What was REVS’s price range in the past 12 months?
REVS lowest ETF price was $25.55 and its highest was $32.21 in the past 12 months.
    What is the AUM of REVS?
    As of Jun 15, 2026 The AUM of REVS is 311.94M.
      Is REVS overvalued?
      According to Wall Street analysts REVS’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does REVS pay dividends?
        REVS pays a Annually dividend of $0.602 which represents an annual dividend yield of 1.88%. See more information on REVS dividends here
          How many shares outstanding does REVS have?
          Currently, no data Available
          Which hedge fund is a major shareholder of REVS?
          Currently, no hedge funds are holding shares in REVS

          REVS ETF Smart Score

          For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.​

          Top 10 Holdings

          Name
          Weight %
          Cisco
          3.85%
          Procter & Gamble Company
          3.24%
          Wells Fargo & Company
          3.20%
          Exxon Mobil Corp.
          3.20%
          Alphabet Inc. Class A
          2.93%
          Advanced Micro Devices, Inc.
          2.74%
          Citigroup Inc
          2.43%
          Alphabet Inc. Class C
          2.38%
          Pfizer Inc
          2.11%
          CVS Health Corp
          1.82%
          Total27.90%
          See All Holdings
          Popular ETFs
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis
          Advertisement